Guest: Joshua Bauml, MD The COVID-19 pandemic has presented a unique and difficult problem for clinicians and patients alike. Here to share how he’s continuing treatment for his patients with non-small cell lung cancer in the era of COVID-19 is Dr. Joshua Bauml, a medical oncologist and Assistant Professor at the Perelman School of Medicine at the University of Pennsylvania.

Closing the Gaps in NSCLC

How COVID-19 Has Impacted the Care Continuum for NSCLC Patients

Not only is lung cancer the leading cause of cancer deaths among females and males, but it’s also the most common type of cancer. Despite its high prevalence and mortality rates, communicative care between non-small cell lung cancer (NSCLC) patients and their providers is still unfortunately lacking. In an effort to both address and resolve this disparity, Closing the Gaps in NSCLC will focus on the latest guidelines and the current therapeutic landscape within NSCLC. This non-certified educational series is sponsored by Lilly. Content for this series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.  Sponsored by

About

Closing the Gaps in NSCLC